Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
256. |
ECCT/21/06/06 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older |
Principal Investigator(s) 1. Janet Oyieko Site(s) in Kenya 1. KEMRI CCR-Butere County Hospital Site (Kakamega county) 2. Kenya Medical Research Institute (Kisumu county) 3. KEMRI/Walter Reed Project Research Center (Kericho county) 4. Ganjoni Clinic (Mombasa county) 5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 6. Kenya Medical Research Institute (Nairobi City county) 7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 8. Moi University Clinical Research Centre (Uasin Gishu county) 9. Aga Khan University Hospital (Nairobi City county) 10. Kenya Medical Research Institute (Kisumu county) 11. KEMRI/Walter Reed Project Research Center (Kericho county) 12. Ganjoni Clinic (Mombasa county) 13. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 14. Kenya Medical Research Institute (Nairobi City county) 15. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 16. Moi University Clinical Research Centre (Uasin Gishu county) 17. Aga Khan University Hospital (Nairobi City county) 18. Kenya Medical Research Institute (Kisumu county) 19. KEMRI/Walter Reed Project Research Center (Kericho county) 20. Ganjoni Clinic (Mombasa county) 21. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 22. Kenya Medical Research Institute (Nairobi City county) 23. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 24. Moi University Clinical Research Centre (Uasin Gishu county) 25. Aga Khan University Hospital (Nairobi City county) 26. Kenya Medical Research Institute (Kisumu county) 27. KEMRI/Walter Reed Project Research Center (Kericho county) 28. Ganjoni Clinic (Mombasa county) 29. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 30. Kenya Medical Research Institute (Nairobi City county) 31. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 32. Moi University Clinical Research Centre (Uasin Gishu county) 33. Aga Khan University Hospital (Nairobi City county) 34. Kenya Medical Research Institute (Kisumu county) 35. KEMRI/Walter Reed Project Research Center (Kericho county) 36. Ganjoni Clinic (Mombasa county) 37. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 38. Kenya Medical Research Institute (Nairobi City county) 39. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 40. Moi University Clinical Research Centre (Uasin Gishu county) 41. Aga Khan University Hospital (Nairobi City county) |
View |
257. |
ECCT/20/10/01 | HIV-CORE 006 A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa. |
Principal Investigator(s) 1. Eduard J Sanders Site(s) in Kenya 1. KEMRI Mtwapa Research Clinic (Kilifi county) 2. KAVI-ICR Nairobi (Nairobi City county) |
View |
258. |
ECCT/20/06/09 | HIV-CORE 006 A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa |
Principal Investigator(s) 1. Professor Walter Jaoko, Jaoko, Site(s) in Kenya 1. KAVI-Institute of Clinical Research (Nairobi City county) 2. KEMRI/ Wellcome Trust Research Programme (Kilifi county) |
View |
259. |
ECCT/23/11/04 | AUB Study A phase 1, single-center, double-blind, randomized, placebo-controlled trial to assess the safety, tolerability and initial efficacy of AHC01 delivered via transcervical catheter in adult females (25-55 years), experiencing abnormal uterine bleeding and scheduled for a hysterectomy. |
Principal Investigator(s) 1. Dr Alice Kaaria Site(s) in Kenya Kenyatta National Hospital (KNH) |
View |
260. |
ECCT/14/02/03 | A Phase 1/2 Randomized, Double-Blind, Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated Streptococcus pneumoniae Whole Cell Vaccine Formulated with Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers (12-15 Months of Age) |
Principal Investigator(s) 1. Nekoye Namungu Otsyula 2. Walter Otieno Site(s) in Kenya Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Kombewa Clinical Research Center |
View |